NCT05260528
|
An ALFA 2101 Multicenter Randomized Phase II Study: CPX-351 Versus Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics (ALFA2101)
|
En recrutement
|
12 juillet 2023
|
NCT03753802
|
Multicenter Randomized Controlled Trial: Evaluation of the Effects of Respiratory Physiotherapy, Placebo-controlled, in Infants With Moderate Acute Bronchiolitis (Bronkiville)
|
Statut inconnu
|
20 mars 2023
|
NCT04863547
|
Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection (SEVASAR)
|
Statut inconnu
|
20 mars 2023
|
NCT03235310
|
ANRS CO1 EPF Prospective Observational Cohort Study on Mother-to-child Transmission HIV1 and/or HIV2 and Prevention (EPF)
|
En recrutement
|
20 mars 2023
|
NCT04885452
|
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') or or Authorisation for Early Access (AAP). A Prospective Cohort.
|
Statut inconnu
|
20 mars 2023
|